Showing results (11-20 of 357) with videos related to

Sort By:
Pageof 36
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1993
Effects of lacidipine on experimental models of atherosclerosisF Bernini, A Corsini, M Raiteri, et al.
Pharmacology & Therapeutics|February 9, 2000
New insights into the pharmacodynamic and pharmacokinetic properties of statinsA Corsini, S Bellosta, R Baetta, et al.
Diabetes Care|June 22, 2000
Pleiotropic effects of statins in atherosclerosis and diabetesS Bellosta, N Ferri, L Arnaboldi, et al.
The American Journal of Cardiology|July 13, 1995
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsA Corsini, M Raiteri, M R Soma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophagesS Bellosta, D Via, M Canavesi, et al.
Pharmacological Research|October 1, 1991
Influence of trapidil and derivatives on cholesterol synthesis and esterification in cultured cellsJ Beitz, A Corsini, S Bellosta, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2001
Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophagesS Bellosta, M Canavesi, E Favari, et al.
Cardiology|November 1, 1996
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsA Corsini, F Bernini, P Quarato, et al.
Atherosclerosis|August 7, 1998
Direct vascular effects of HMG-CoA reductase inhibitorsS Bellosta, F Bernini, N Ferri, et al.
Blood Pressure. Supplement|December 16, 1998
The new calcium antagonist lercanidipine and its enantiomers affect major processes of atherogenesis in vitro: is calcium entry involved?A Corsini, M R Accomazzo, M Canavesi, et al.
Pageof 36